Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Genomic technologies accelerate discovery of germline genetic variations linked to hematologic diseases.
• GATA2 gene variations predispose individuals to bone marrow failure and acute myeloid leukemia, known as GATA2 deficiency syndrome.
• Over 300 GATA2 variants, including missense, truncating, and noncoding mutations, have been identified, but their functional impact is often unclear.

Purpose of the Study:

• To review the human genetics of GATA2.
• To explore the functional consequences of GATA2 variants.
• To bridge the gap between physiological insights and pathogenic mechanisms of GATA2 deficiency syndrome.

Main Methods:

• Review of documented GATA2 variants.
• Analysis of studies using genetic rescue and knockin mouse models.
• Examination of context-dependent effects of GATA2 mutations on gene expression and cellular processes.

Main Results:

• GATA2 variants can reduce gene expression or function.
• Studies demonstrate that GATA2 mutations differentially impact molecular processes in various genes and cell types.
• Experimental findings suggest context-dependent consequences of GATA2 mutations.

Conclusions:

• The functional ramifications of many GATA2 variants remain to be elucidated.
• Cell-type specificity and differential target gene sensitivity contribute to the complex phenotypes observed in GATA2 deficiency syndrome.
• Further research is needed to fully understand the pathogenic mechanisms underlying GATA2-related disorders.